Multiple-dose Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis
Phase 1
Completed
- Conditions
- Actinic Keratosis
- Interventions
- Drug: SR-T100 Gel
- First Posted Date
- 2015-09-25
- Last Posted Date
- 2019-07-15
- Lead Sponsor
- G&E Herbal Biotechnology Co., LTD
- Target Recruit Count
- 12
- Registration Number
- NCT02559934
- Locations
- 🇨🇳
National Cheng Kung University Hospital, Tainan, Taiwan
Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis
Phase 2
Completed
- Conditions
- Actinic KeratosisBowen's Disease
- Interventions
- Drug: SR-T100 ® Gel
- First Posted Date
- 2014-03-12
- Last Posted Date
- 2014-03-14
- Lead Sponsor
- G&E Herbal Biotechnology Co., LTD
- Target Recruit Count
- 27
- Registration Number
- NCT02085395
- Locations
- 🇨🇳
National Cheng Kung University Hospital, Tainan, Taiwan
Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis
Phase 1
Completed
- Conditions
- Actinic Keratosis
- Interventions
- Drug: SR-T100 gel
- First Posted Date
- 2014-01-07
- Last Posted Date
- 2015-08-13
- Lead Sponsor
- G&E Herbal Biotechnology Co., LTD
- Target Recruit Count
- 2
- Registration Number
- NCT02029066
- Locations
- 🇨🇳
National Cheng Kung University Hospital, Tainan, Taiwan
Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients
Phase 2
Suspended
- Conditions
- Common Wart
- Interventions
- Drug: Vehicle gelDrug: SR-T100 gel with 1.0% of SMDrug: SR-T100 gel with 2.3% of SM
- First Posted Date
- 2013-02-22
- Last Posted Date
- 2023-09-14
- Lead Sponsor
- G&E Herbal Biotechnology Co., LTD
- Target Recruit Count
- 102
- Registration Number
- NCT01796795
Efficacy and Safety Profiles of SR-T100 Gel on External Genital Warts/Condyloma Acuminate(EGWs)
Phase 2
Completed
- Conditions
- Genital WartsVenereal WartsCondylomata AcuminataCondyloma Acuminata
- Interventions
- Drug: SR-T100 gel with 1.0 % SMDrug: Vehicle gelDrug: SR-T100 gel with 2.3% SM
- First Posted Date
- 2013-02-22
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- G&E Herbal Biotechnology Co., LTD
- Target Recruit Count
- 138
- Registration Number
- NCT01796821
- Locations
- 🇨🇳
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
🇨🇳Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan
🇨🇳National Cheng Kung University Hospital, Tainan, Taiwan
Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis
Phase 2
Completed
- Conditions
- Actinic Keratosis
- Interventions
- Drug: Vehicle gelDrug: SR-T100 with 2.3% of SM
- First Posted Date
- 2012-01-25
- Last Posted Date
- 2018-12-05
- Lead Sponsor
- G&E Herbal Biotechnology Co., LTD
- Target Recruit Count
- 86
- Registration Number
- NCT01516515
- Locations
- 🇺🇸
Pflugerville Dermatology Clinical Research, Pflugerville, Texas, United States
🇺🇸The Education & Research Foundation, Inc, Lynchburg, Virginia, United States
🇺🇸Suzanne Bruce and Associates,P.A. The Center for Skin Research, Katy, Texas, United States
Efficacy Study & Safety Evaluation of SR-T100 Gel in Actinic Keratosis Treatment
Phase 3
Completed
- Conditions
- Actinic Keratosis
- Interventions
- Drug: SR-T100 gelDrug: Vehicle gel
- First Posted Date
- 2011-12-16
- Last Posted Date
- 2016-02-19
- Lead Sponsor
- G&E Herbal Biotechnology Co., LTD
- Target Recruit Count
- 113
- Registration Number
- NCT01493921
- Locations
- 🇨🇳
Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
🇨🇳Chi Mei Medical Center YongKang, Tainan, Taiwan
🇨🇳Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan
© Copyright 2025. All Rights Reserved by MedPath